Taha
Abed Al Hay Taha, Chur CH
Patent application number | Description | Published |
---|---|---|
20110162582 | DEPOSITION OF ACTIVE FILMS - A plasma reactor ( | 07-07-2011 |
20130052369 | PLASMA REACTOR - A plasma reactor with a recipient ( | 02-28-2013 |
Ameer Y. Taha, Toronto CA
Patent application number | Description | Published |
---|---|---|
20110054199 | Methods for extracting nutrients, drugs and toxins from a sample, and apparati for same - Provided is a novel method for extracting nutrients, toxins and drugs from a solid sample, comprising adding a solvent such as hexane and isopropanol to said sample, subjecting the sample and solvent to ultrasonic energy, subjecting the sample and solvent to heat, then removing the solvent liquid fraction from what remains of the sample. | 03-03-2011 |
20140339160 | METHOD, APPARATUS AND KIT FOR THE EXTRACTION OF LIPID-SOLUBLE COMPOUNDS - A method of separating an aqueous portion from a heterogeneous sample containing said aqueous portion and a non-aqueous (lipid) portion, teaches passing a sample through glass wool, thus trapping the aqueous layer in the glass wool and eluting the lipid layer from the glass wool. | 11-20-2014 |
Bachar Taha, Hardy Bagneux FR
Patent application number | Description | Published |
---|---|---|
20150024332 | ANCHOR PLATE IN ORTHODONTICS - Disclosed is an orthodontics element which may be interdependent of a jaw bone. The orthodontics element includes firstly a plate ( | 01-22-2015 |
Doris Taha, Jeddah SA
Patent application number | Description | Published |
---|---|---|
20110112015 | USE OF GLIS3 FOR PREPARING FUNCTIONAL PANCREATIC BETA-CELLS - The present invention relates to a method of diagnosis of neonatal diabetes, congenital hypothyroidism and congenital glaucoma, comprising detecting the presence of a mutation in the GLIS3 gene and to a method for preparing functional pancreatic beta-cells by culturing human multipotent or pluripotent cells, such as embryonic stem cells (ES-cells) or human somatic stem cells in a culture medium comprising a effective amount of GLIS3 to induce said cells differenciation into functional pancreatic beta-cells producing insulin. It also relates to a pharmaceutical composition comprising GLIS3 as active ingredient. | 05-12-2011 |
Gaith S. Taha, Aylesbury GB
Patent application number | Description | Published |
---|---|---|
20130276111 | SYSTEM, METHOD, AND COMPUTER PROGRAM PRODUCT FOR PROVIDING AT LEAST ONE STATISTIC ASSOCIATED WITH A POTENTIALLY UNWANTED ACTIVITY TO A USER - A system, method, and computer program product provide at least one statistic associated with a potentially unwanted activity to a user. In use, a potentially unwanted activity is identified. Further, at least one statistic associated with at least one characteristic of the potentially unwanted activity is determined. Additionally, the at least one statistic is provided to a user. | 10-17-2013 |
Hadeel Taha, Ludwigshafen DE
Patent application number | Description | Published |
---|---|---|
20130102438 | Vehicle Speed Control System - A method of controlling an engine and a transmission coupled to the engine. The method including the steps of receiving and proceeding. The receiving step receives a signal value from a sensor. The signal value is representative of a desired ground engaging device speed of a vehicle. The proceeding step proceeds along a shift path defined by a one-to-one correspondence between the signal value and the ground engaging device speed. The proceeding step includes the steps of controlling a speed of the engine and selecting of a gear of the transmission along the shift path dependent upon the signal value. | 04-25-2013 |
Mahmoud Fawzy Taha, Hawally KW
Patent application number | Description | Published |
---|---|---|
20160052823 | PROCESS USING MULTIPLE WASTE STREAMS TO MANUFACTURE SYNTHETIC LIGHTWEIGHT AGGREGATE - The process using multiple waste streams to manufacture synthetic lightweight aggregate includes providing a mixture of aggregate wash and at least one of another waste stream, such as waste lube oil or sewage sludge. The mixture is formed into pellets and subjected to various firing stages and temperatures in which the calcination and subsequent bloating occurs. The mixture can also be added to natural clays to form corresponding pellets. The bloating promotes formation of porous cavities, and once cooled, the pellets form lightweight, low density synthetic aggregates suitable for use as building materials, thermal insulators, and the like. | 02-25-2016 |
Mohamad Saeed Taha, Luran Alexandria EG
Patent application number | Description | Published |
---|---|---|
20130344458 | Process for securing a dental implant and dental implant - The present invention concerns a method for inserting a dental implant into the jawbone as a replacement for a tooth, said jawbone comprising cortical bone matter surrounding a core of spongy bone, wherein a hole is excavated in the cortical bone of the upper surface of the jawbone using an excavation tool, said hole penetrating mainly the cortical bone matter of the jawbone. The excavation tool is then removed and a threaded implant is placed in the excavated hole of the upper surface of the jawbone; the threaded implant is forwarded into the spongy bone core of the jawbone without any prior drilling having been done into the spongy bone section of the jawbone; and the implant is left in the spongy bone core of the jawbone for promoting integration of the implant with the surrounding bone (Osteointegration). The invention also concerns a dental implant suitable for being used in the method, said dental implant comprising an osseoimplant (Osseous part) part ( | 12-26-2013 |
Mohamed A. Taha, Zurich CH
Patent application number | Description | Published |
---|---|---|
20120041751 | Evaluating And Modifying Transliteration Rules - Methods, systems, and apparatus, including computer programs encoded on computer storage media, for adjusting transliteration weights. One methods includes maintaining transliteration rules and a weight for each rule and receiving training pairs comprising a first word in a first writing system and a second word in a second writing system, where the second word is a transliteration of the first word. The method further includes processing the training pairs to determine, for each transliteration rule, one or more good weight adjustments and one or more bad weight adjustments, and for one or more of the transliteration rules, selecting a good weight adjustment for the transliteration rule that has a highest associated gain and updating the weight for the transliteration rule to reflect the selected good weight adjustment for the rule. | 02-16-2012 |
Muhamed-Kheir Taha, Chennevieres FR
Patent application number | Description | Published |
---|---|---|
20090053237 | USE OF PENICILLIN-BINDING PROTEINS OR POLYNUCLEOTIDES OR ANTIBODIES THEREOF FOR PREVENTING OR TREATING BACTERIAL INFECTIONS - The present invention is drawn to a penicillin-binding protein expressed by | 02-26-2009 |
Othman A. Taha, Dhahran SA
Patent application number | Description | Published |
---|---|---|
20090095657 | Automation and Control of Energy Efficient Fluid Catalytic Cracking Processes for Maximizing Value Added Products - With an aim to optimize propylene production, petroleum oil is catalytically cracked by contacting the oil with catalyst mixture consisting of a base cracking catalyst containing an stable Y-type zeolite and small amounts of rare-earth metal oxide, and an additive containing a shape-selective zeolite, in an up-flow type fluid catalytic cracking apparatus having a regeneration zone, a separation zone, and a stripping zone. According to this fluid catalytic cracking process, the production of light-fraction olefins such as propylene is maximized by applying appropriate process control, monitoring, and optimizing systems. The present invention provides mathematical process models, including: neural networks, statistical models and finite impulse models. These various mathematical process models are used in conjunction with advanced controllers and optimizing routines to calculate optimal settings for various process parameters. A microwave based system can also be employed for optimizing the performance of a stripping zone, which further optimizes catalyst regeneration. Process model and historical data to test a predictive system can provide early warning of potential performance degradation and equipment failure in the FCC unit, which decreases overall operating costs and increases plant safety. | 04-16-2009 |
20090248174 | CONTROL METHOD OF REFRIGERATION SYSTEMS IN GAS PLANTS WITH PARALLEL TRAINS - An optimization method based on statistical modeling relating NGL plant process variables. The modeling may rely on input data from process history and modeled data. The method identifies process scenarios when a compressor from an associated propane/propylene refrigeration system may be deactivated and still allow the NGL plant to achieve product specification. | 10-01-2009 |
20100230324 | Control of Fluid Catalytic Cracking Process for Minimizing Additive Usage in the Desulfurization of Petroleum Feedstocks - A method and apparatus for the cracking of a petroleum oil feedstock to produce a desulfurized full-range gasoline product. The petroleum oil feedstock is contacted with a base cracking catalyst and an FCC additive in an FCC unit, wherein the catalyst includes a stable Y-type zeolite and a rare-earth metal oxide and the additive includes a shape selective zeolite. The catalyst, additive and petroleum oil feedstock can be contacted in a down-flow or riser fluid catalytic cracking unit, that can also include a regeneration zone, a separation zone, and a stripping zone. The FCC unit includes an integrated control and monitoring system that monitors at least one parameter selected from FCC operating parameters, feed rate, feedstock properties, and product stream properties, and adjusts at least one parameter in response to the measured parameter to increase production of desulfurized products. | 09-16-2010 |
20120193269 | AUTOMATION AND CONTROL OF ENERGY EFFICIENT FLUID CATALYTIC CRACKING PROCESSES FOR MAXIMIZING VALUE ADDED PRODUCTS - Petroleum oil is catalytically cracked by contacting oil with catalyst mixture consisting of a base cracking catalyst containing an stable Y-type zeolite and small amounts of rare-earth metal oxide, and an additive containing a shape-selective zeolite, in an FCC apparatus having a regeneration zone, a separation zone, and a stripping zone. Production of light-fraction olefins is maximized by applying appropriate process control, monitoring, and optimizing systems. Mathematical process models, including neural networks, statistical models and finite impulse models are used in conjunction with advanced controllers and optimizing routines to calculate optimal settings for various parameters. Process model and historical data to test a predictive system can provide early warning of potential performance degradation and equipment failure in the FCC unit, decreasing overall operating costs and increasing plant safety. | 08-02-2012 |
Safa Taha, Manama BH
Patent application number | Description | Published |
---|---|---|
20100218265 | IMMUNE SYSTEM MEDIATOR - The present invention discloses an isolated nucleic acid molecule encoding an ISRAA polypeptide comprising a nucleotide sequence exhibiting at least 70% homology to the sequence represented by the nucleotide sequence SEQ ID No: 1. Also disclosed is a recombinant expression vector comprising said nucleic acid molecule and an isolated polypeptide molecule encoded by said nucleic acid molecule. | 08-26-2010 |
20140356368 | APPLICATIONS OF AN IMMUNE SYSTEM-RELEASED ACTIVATING AGENT (ISRAA) - The present invention relates to applications of an immune system-released activating agent (ISRAA) polypeptide, which is induced by a nervous stimulus and which has been found to mediate the transmission of signals between the immune system and the nervous system following an immune challenge. Here, the ISRAA polypeptide is for use in a method of treatment of patients with immunodeficiency, immunosuppression or autoimmune disease; cancer; neurologic diseases and disorders; or muscular diseases and disorders. | 12-04-2014 |
20150203544 | IMMUNE SYSTEM MEDIATOR - The present invention discloses an isolated nucleic acid molecule encoding an ISRAA polypeptide comprising a nucleotide sequence exhibiting at least 70% homology to the sequence represented by the nucleotide sequence SEQ ID No: 1. Also disclosed is a recombinant expression vector comprising said nucleic acid molecule and an isolated polypeptide molecule encoded by said nucleic acid molecule. | 07-23-2015 |